Literature DB >> 26688289

A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder.

Bernhard T Baune1, Gin S Malhi2,3.   

Abstract

OBJECTIVES: Bipolar disorder (BD) is associated with significant impairment in cognitive performance across multiple domains of function that often persist after clinical recovery. It remains unclear, however, as to whether this process is related to the clinical status of BD being depressed, manic/hypomanic, or euthymic. In this review, we examine the literature on the cross-sectional and longitudinal relationships between cognitive function and general function depending on the clinical phase of BD.
METHODS: A systematic review of original research that studied both cognitive function and general function in adults (18-60 years), restricted to BD, was conducted in a total of 18 studies meeting inclusion/exclusion criteria.
RESULTS: Results show cross-sectional and prospective relationships between cognitive function and general function in patients with BD in both symptomatic and euthymic patients with BD. While studies using general measures of function (e.g., Global Assessment of Function scale) show more inconsistent associations with cognitive function, those employing assessments of domain specific function, suggest a consistent relationship between social and occupational function and cognitive performance. Executive function is commonly affected by cognitive deficits in these patients, but in addition a variety of domains show associations with functional outcomes (e.g., social function, occupational function). Notably, the emerging evidence suggests that cognitive function may be a better predictor of future general function than affective symptom severity.
CONCLUSIONS: Despite some inconsistencies, in sum the literature on the relationship between cognitive function and general function in BD implicates both cross-sectional and longitudinal associations, both in symptomatic and euthymic patients with BD. And in terms of capturing these changes functional scales in particular domain-specific measures seem superior to general measures.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bipolar disorder; cognitive function; depression; general function; mood state; neurobiology

Mesh:

Year:  2015        PMID: 26688289     DOI: 10.1111/bdi.12341

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  32 in total

1.  Neuropsychological predictors of performance-based measures of functional capacity and social skills in individuals with severe mental illness.

Authors:  Zanjbeel Mahmood; Cynthia Z Burton; Lea Vella; Elizabeth W Twamley
Journal:  J Psychiatr Res       Date:  2018-04-13       Impact factor: 4.791

Review 2.  Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological Treatment.

Authors:  Ni Xu; Benjamin Huggon; Kate E A Saunders
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749

Review 3.  The difficult lives of individuals with bipolar disorder: A review of functional outcomes and their implications for treatment.

Authors:  Michael J Gitlin; David J Miklowitz
Journal:  J Affect Disord       Date:  2016-11-22       Impact factor: 4.839

4.  The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis.

Authors:  M Morrens; C Overloop; V Coppens; E Loots; M Van Den Noortgate; S Vandenameele; M Leboyer; L De Picker
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

5.  Long-term work disability due to type I and II bipolar disorder: findings of a six-year prospective study.

Authors:  Petri Arvilommi; Sanna Pallaskorpi; Outi Linnaranta; Kirsi Suominen; Sami Leppämäki; Hanna Valtonen; Erkki Isometsä
Journal:  Int J Bipolar Disord       Date:  2022-07-11

6.  The effects of cognitive remediation on cognitive abilities and real-world functioning among people with bipolar disorder: A systematic review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.

Authors:  Marcella Bellani; Bruno Biagianti; Niccolò Zovetti; Maria Gloria Rossetti; Cinzia Bressi; Cinzia Perlini; Paolo Brambilla
Journal:  J Affect Disord       Date:  2019-07-19       Impact factor: 4.839

7.  Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging.

Authors:  Thilo Deckersbach; Amy T Peters; Conor Shea; Aishwarya Gosai; Jonathan P Stange; Andrew D Peckham; Kristen K Ellard; Michael W Otto; Scott L Rauch; Darin D Dougherty; Andrew A Nierenberg
Journal:  J Affect Disord       Date:  2017-12-27       Impact factor: 4.839

8.  Social cognition moderates the relationship between neurocognition and community functioning in bipolar disorder.

Authors:  L H Ospina; G C Nitzburg; M Shanahan; M M Perez-Rodriguez; E Larsen; A Latifoglu; K E Burdick
Journal:  J Affect Disord       Date:  2018-03-29       Impact factor: 4.839

9.  Understanding cognitive impairment in mood disorders: mediation analyses in the UK Biobank cohort.

Authors:  Breda Cullen; Daniel J Smith; Ian J Deary; Jill P Pell; Katherine M Keyes; Jonathan J Evans
Journal:  Br J Psychiatry       Date:  2019-11       Impact factor: 9.319

10.  Seasonality in Bipolar Disorder: Impact on Mood Symptoms, Psychosocial Functioning, Neurocognition, and Biological Rhythm.

Authors:  Fikret Poyraz Çökmüş; Kadir Aşçibaşi; Didem SüCüllüoğlu Dikici; Emine Özge Çöldür; Emin Avci; Ömer Aydemir
Journal:  Noro Psikiyatr Ars       Date:  2020-11-19       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.